| Literature DB >> 22449171 |
Yoshihiro Miyake1, Keiko Tanaka, Hitomi Okubo, Satoshi Sasaki, Masashi Arakawa.
Abstract
BACKGROUND: Dietary fat exerts numerous complex effects on proinflammatory and immunologic pathways. Several epidemiological studies have examined the relationships between intake of fatty acids and/or foods high in fat and allergic rhinitis, but have provided conflicting findings. The current cross-sectional study investigated such relationships in Japan.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22449171 PMCID: PMC3342884 DOI: 10.1186/1475-2891-11-19
Source DB: PubMed Journal: Nutr J ISSN: 1475-2891 Impact factor: 3.271
Distribution of selected characteristics in 1745 pregnant women, Kyushu Okinawa Maternal and Child Health Study, Japan
| Variable | |
|---|---|
| Age, years, mean ± SD | 31.2 ± 4.3 |
| Gestation, weeks, mean ± SD | 18.5 ± 5.4 |
| Region of residence | |
| Fukuoka Prefecture | 971 (55.6) |
| Other than Fukuoka Prefecture in Kyushu | 592 (33.9) |
| Okinawa Prefecture | 182 (10.4) |
| Having one or more older siblings | 914 (52.4) |
| Having one or more children | 1042 (59.7) |
| Having ever smoked | 563 (32.3) |
| Ever experiencing secondhand smoke exposure at home | 1315 (75.4) |
| Ever experiencing secondhand smoke exposure at work | 1106 (63.4) |
| Family history of asthma | 330 (18.9) |
| Family history of atopic eczema | 303 (17.4) |
| Family history of allergic rhinitis | 759 (43.5) |
| Household income, yen/year | |
| < 4,000,000 | 632 (36.2) |
| 4,000,000-5,999,999 | 618 (35.4) |
| ≥ 6,000,000 | 495 (28.4) |
| Education, years | |
| < 13 | 428 (24.5) |
| 13-14 | 577 (33.1) |
| ≥ 15 | 740 (42.4) |
| Body mass index, kg/m2, mean ± SD | 21.4 ± 2.8 |
Distribution of daily intake in 1745 pregnant women, Kyushu Okinawa Maternal and Child Health Study, Japan*
| Variable | Mean (SD) |
|---|---|
| Total energy, kJ | 7434.2 (2057.0) |
| Meat, g | 64.4 (28.8) |
| Fish, g | 46.7 (25.8) |
| Total fat, g | 58.0 (11.5) |
| Saturated fatty acids, g | 16.8 (4.3) |
| Monounsaturated fatty acids, g | 20.3 (4.9) |
| n-3 Polyunsaturated fatty acids, g | 2.3 (0.7) |
| α-Linolenic acid, g | 1.7 (0.5) |
| Eicosapentaenoic acid, g | 0.17 (0.12) |
| Docosahexaenoic acid, g | 0.29 (0.17) |
| n-6 Polyunsaturated fatty acids, g | 11.0 (2.5) |
| Linoleic acid, g | 10.7 (2.4) |
| Arachidonic acid, g | 0.13 (0.04) |
| Cholesterol, mg | 284.6 (96.4) |
* Nutrient and food intake were adjusted for total energy intake using the residual method
Odds ratios (ORs) and 95% confidence intervals (CIs) for rhinoconjunctivitis by quartiles of intake of meat and fish in 1745 pregnant women, Kyushu Okinawa Maternal and Child Health Study, Japan
| Variable | Quartile | ||||
|---|---|---|---|---|---|
| 1 (Lowest) (n = 436) | 2 (n = 436) | 3 (n = 436) | 4 (Highest) (n = 437) | ||
| Meat | |||||
| Intake, g/day* | 35.1 | 54.0 | 70.2 | 95.6 | |
| Prevalence, %† | 20.6 | 26.2 | 26.2 | 30.7 | |
| Crude OR (95% CI) | 1.00 | 1.36 (0.99-1.87) | 1.36 (0.99-1.87) | 1.70 (1.25-2.32) | 0.001 |
| Adjusted OR (95% CI)‡ | 1.00 | 1.37 (0.99-1.89) | 1.34 (0.97-1.85) | 1.71 (1.25-2.35) | 0.002 |
| Fish | |||||
| Intake, g/day* | 22.8 | 37.2 | 49.5 | 71.7 | |
| Prevalence, %† | 26.8 | 24.3 | 27.3 | 25.2 | |
| Crude OR (95% CI) | 1.00 | 0.88 (0.65-1.19) | 1.02 (0.76-1.38) | 0.92 (0.68-1.24) | 0.83 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.82 (0.60-1.12) | 0.98 (0.72-1.33) | 0.87 (0.63-1.19) | 0.63 |
* Values for intake are medians for adjusted energy intake using the residual method for each quartile.
† Prevalence of rhinoconjunctivitis based on the International Study of Asthma and Allergies in Childhood for each quartile.
‡ Adjustment for age; gestation; region of residence; number of older siblings; number of children; smoking; secondhand smoke exposure at home and at work; family history of asthma, atopic eczema, and allergic rhinitis; household income; education; and body mass index.
Odds ratios (ORs) and 95% confidence intervals (CIs) for rhinoconjunctivitis by quartiles of intake of specific fats in 1745 pregnant women, Kyushu Okinawa Maternal and Child Health Study, Japan
| Quartile | |||||
|---|---|---|---|---|---|
| Variable | 1 (Lowest) (n = 436) | 2 (n = 436) | 3 (n = 436) | 4 (Highest) (n = 437) | |
| Total fat | |||||
| Intake, g/day* | 47.2 | 54.7 | 60.4 | 69.7 | |
| Prevalence, %† | 23.9 | 25.2 | 25.7 | 28.8 | |
| Crude OR (95% CI) | 1.00 | 1.08 (0.79-1.47) | 1.10 (0.81-1.50) | 1.29 (0.96-1.75) | 0.10 |
| Adjusted OR (95% CI)‡ | 1.00 | 1.09 (0.79-1.49) | 1.11 (0.81-1.53) | 1.31 (0.96-1.79) | 0.09 |
| Saturated fatty acids | |||||
| Intake, g/day* | 12.6 | 15.5 | 17.6 | 21.2 | |
| Prevalence, %† | 25.7 | 25.2 | 23.6 | 29.1 | |
| Crude OR (95% CI) | 1.00 | 0.98 (0.72-1.32) | 0.90 (0.66-1.22) | 1.19 (0.88-1.60) | 0.36 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.99 (0.72-1.35) | 0.96 (0.70-1.32) | 1.20 (0.88-1.63) | 0.29 |
| Monounsaturated fatty acids | |||||
| Intake, g/day* | 15.7 | 18.9 | 21.2 | 25.0 | |
| Prevalence, %† | 24.3 | 25.0 | 25.9 | 28.4 | |
| Crude OR (95% CI) | 1.00 | 1.04 (0.76-1.41) | 1.09 (0.80-1.48) | 1.23 (0.91-1.67) | 0.16 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.99 (0.72-1.36) | 1.08 (0.79-1.48) | 1.19 (0.87-1.63) | 0.21 |
| n-3 Polyunsaturated fatty acids | |||||
| Intake, g/day* | 1.7 | 2.1 | 2.4 | 2.9 | |
| Prevalence, %† | 25.5 | 25.2 | 24.8 | 28.2 | |
| Crude OR (95% CI) | 1.00 | 0.99 (0.73-1.34) | 0.96 (0.71-1.31) | 1.15 (0.85-1.55) | 0.42 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.92 (0.67-1.26) | 0.90 (0.65-1.23) | 1.07 (0.78-1.45) | 0.72 |
| α-Linolenic acid | |||||
| Intake, g/day* | 1.2 | 1.5 | 1.8 | 2.2 | |
| Prevalence, %† | 25.0 | 23.2 | 28.2 | 27.2 | |
| Crude OR (95% CI) | 1.00 | 0.90 (0.66-1.23) | 1.18 (0.87-1.59) | 1.12 (0.83-1.52) | 0.21 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.88 (0.64-1.21) | 1.18 (0.86-1.60) | 1.04 (0.76-1.42) | 0.43 |
| Eicosapentaenoic acid | |||||
| Intake, g/day* | 0.07 | 0.12 | 0.17 | 0.29 | |
| Prevalence, %† | 25.7 | 25.2 | 27.1 | 25.6 | |
| Crude OR (95% CI) | 1.00 | 0.98 (0.72-1.32) | 1.07 (0.79-1.45) | 1.00 (0.74-1.35) | 0.86 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.91 (0.67-1.25) | 1.00 (0.73-1.37) | 0.93 (0.68-1.28) | 0.81 |
| Docosahexaenoic acid | |||||
| Intake, g/day* | 0.14 | 0.22 | 0.30 | 0.46 | |
| Prevalence, %† | 25.2 | 25.2 | 29.4 | 23.8 | |
| Crude OR (95% CI) | 1.00 | 1.00 (0.74-1.36) | 1.23 (0.91-1.66) | 0.93 (0.68-1.26) | 0.98 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.93 (0.68-1.27) | 1.13 (0.83-1.54) | 0.88 (0.64-1.21) | 0.73 |
| n-6 Polyunsaturated fatty acids | |||||
| Intake, g/day* | 8.5 | 10.2 | 11.5 | 13.5 | |
| Prevalence, %† | 24.3 | 23.2 | 30.1 | 26.1 | |
| Crude OR (95% CI) | 1.00 | 0.94 (0.69-1.28) | 1.34 (0.99-1.81) | 1.10 (0.81-1.49) | 0.19 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.91 (0.66-1.26) | 1.34 (0.98-1.83) | 1.05 (0.77-1.45) | 0.29 |
| Linoleic acid | |||||
| Intake, g/day* | 8.3 | 10.0 | 11.3 | 13.1 | |
| Prevalence, %† | 24.3 | 23.6 | 29.1 | 26.5 | |
| Crude OR (95% CI) | 1.00 | 0.96 (0.71-1.31) | 1.28 (0.95-1.73) | 1.13 (0.83-1.53) | 0.19 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.94 (0.68-1.29) | 1.27 (0.93-1.73) | 1.08 (0.79-1.48) | 0.30 |
| Arachidonic acid | |||||
| Intake, g/day* | 0.09 | 0.12 | 0.14 | 0.18 | |
| Prevalence, %† | 25.0 | 24.1 | 28.4 | 26.1 | |
| Crude OR (95% CI) | 1.00 | 0.95 (0.70-1.30) | 1.19 (0.88-1.61) | 1.06 (0.78-1.44) | 0.42 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.90 (0.65-1.23) | 1.20 (0.88-1.63) | 1.05 (0.77-1.43) | 0.39 |
| n-3/n-6 Polyunsaturated fatty acid ratio | |||||
| Intake* | 0.17 | 0.19 | 0.21 | 0.25 | |
| Prevalence, %† | 24.8 | 26.8 | 27.8 | 24.3 | |
| Crude OR (95% CI) | 1.00 | 1.11 (0.82-1.51) | 1.17 (0.86-1.58) | 0.97 (0.71-1.32) | 0.95 |
| Adjusted OR (95% CI)‡ | 1.00 | 1.07 (0.78-1.46) | 1.07 (0.78-1.46) | 0.92 (0.67-1.26) | 0.61 |
| Cholesterol | |||||
| Intake, mg/day* | 182.0 | 244.5 | 308.0 | 402.7 | |
| Prevalence, %† | 26.4 | 22.5 | 28.0 | 26.8 | |
| Crude OR (95% CI) | 1.00 | 0.81 (0.59-1.10) | 1.09 (0.81-1.46) | 1.02 (0.76-1.38) | 0.48 |
| Adjusted OR (95% CI)‡ | 1.00 | 0.82 (0.60-1.13) | 1.10 (0.81-1.49) | 1.05 (0.77-1.42) | 0.41 |
* Values for intake are medians for adjusted energy intake using the residual method for each quartile.
† Prevalence of rhinoconjunctivitis based on the International Study of Asthma and Allergies in Childhood for each quartile.
‡ Adjustment for age; gestation; region of residence; number of older siblings; number of children; smoking; secondhand smoke exposure at home and at work; family history of asthma, atopic eczema, and allergic rhinitis; household income; education; and body mass index.